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Inhibitor of apoptosis (IAP) proteins cIAP1, cIAP2, and
XIAP (X-linked IAP) regulate apoptosis and cytokine
receptor signalling, but their overlapping functions make
it difficult to distinguish their individual roles. To do so,
we deleted the genes for IAPs separately and in combina-
tion. While lack of any one of the IAPs produced no overt
phenotype in mice, deletion of cIap1 with cIap2 or Xiap
resulted in mid-embryonic lethality. In contrast, Xiap/
cIap2/ mice were viable. The death of cIap2/cIap1/
double mutants was rescued to birth by deletion of tumour
necrosis factor (TNF) receptor 1, but not TNFR2 genes.
Remarkably, hemizygosity for receptor-interacting protein
kinase 1 (Ripk1) allowed Xiap/cIap1/ double mutants
to survive past birth, and prolonged cIap2/cIap1/
embryonic survival. Similarly, deletion of Ripk3 was able
to rescue the mid-gestation defect of cIap2/cIap1/
embryos, as these embryos survived to E15.5. cIAPs are
therefore required during development to limit activity of
RIP kinases in the TNF receptor 1 signalling pathway.
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Introduction
The cellular inhibitor of apoptosis (IAP) protein cIAP1
(Birc2), cIAP2 (Birc3), and XIAP (X-linked IAP, Birc4) were
initially identified by their similarity to baculoviral IAP genes,
and, in the case of cIAP1 and cIAP2, also because they bound
to tumour necrosis factor (TNF) receptor-associated proteins
(TRAFs) 1 and 2 (Rothe et al, 1995; Duckett et al, 1996; Liston
et al, 1996; Uren et al, 1996). Cellular IAPs and XIAP are very
similar proteins and belong to the BIRC (baculoviral IAP
repeat containing) protein family, as they all bear three BIR
domains, a ubiquitin-associated domain and a carboxy-term-
inal RING domain, which functions as an E3 ligase
(Birnbaum et al, 1994; Gyrd-Hansen et al, 2008). Cellular
IAP1 and IAP2 also both bear a caspase activation and
recruitment domain, and appear to have arisen from a recent
gene duplication event. They are therefore likely to have
similar functions. Only XIAP is a direct inhibitor of caspase
activity, and can potently inhibit caspase 3, 7, and 9 (Tenev
et al, 2005; Eckelman et al, 2006).
Cellular IAPs 1 and 2 regulate various signalling pathways
that promote activation of canonical NF-kB, but reduce
activation of non-canonical NF-kB transcription factors
(Vince et al, 2007; Hayden and Ghosh, 2008; Gyrd-Hansen
and Meier, 2010). For example, in cells that have not been
exposed to cytokines cIAPs reduce levels of the NF-kB indu-
cing kinase, NIK (Varfolomeev et al, 2007; Vince et al, 2007),
but binding of the TNF superfamily member TWEAK to its
receptor leads to degradation of TRAF2 and cIAPs, so that
NIK is stabilized, and activates non-canonical NF-kB (Vince
et al, 2008). On the other hand, ligation of TNFR1 by TNF
triggers formation of a multiprotein complex containing
TRADD (TNFR1-associated death domain protein), TRAF2,
and RIPK1 (receptor-interacting protein kinase 1). IAP-
mediated ubiquitylation within the TNF receptor signalling
complex leads to activation of TGF-b-activated kinase 1
(TAK1) and NF-kB essential modulator (NEMO/IKKg) com-
plexes, which in turn cause phosphorylation and degradation
of IkB, and activation of p65/RelA canonical NF-kB (Micheau
and Tschopp, 2003; Takaesu et al, 2003; Bertrand et al, 2008).
However, the overlapping functions of cIAP1 and cIAP2 make
it difficult to distinguish the precise role of each.
Deletion of genes in mice can often reveal their roles in
development and in disease, and these roles can be distin-
guished by analysis of compound mutants. However, because
the mouse cIap2 and cIap1 genes are only B15 kb apart on
chromosome 9A2 (Liston et al, 1997), they operate as a single
locus, it has not been possible to generate cIap2/cIap1
double-knockout (DKO) mice by crossing single-KO strains.
In the light of the similar and partially overlapping roles and
functions of cIAP1, cIAP2, and XIAP, we sequentially targeted
the same chromosome in ES cells to make conditional alleles
of both cIap1 and cIap2. We crossed these mice with Xiap
mutant mice to generate mice lacking combinations of two
genes, and studied their development in vivo. We isolated
single and compound IAP mutant cell lines to study the
redundant and individual functions of IAPs in vitro.
Results
Generation of a double IAPs mutant allele
The mouse cIap2 and cIap1 genes are so close that it is
impractical to delete them both by crossing individual KO
lines. By re-targeting the same chromosome in ES cells, we
have generated mice that bear a loxP-flanked cIap1 exon 1 as
well as frt-flanked cIap2 exons 2 and 3, so that both genes can
be conditionally deleted either separately or together
(Gardam et al, 2011) (Figure 1A). These loxP–frt-flankedReceived: 17 October 2011; accepted: 11 January 2012
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Figure 1 Deletion of cIap1 plus cIap2, or cIap1 plus Xiap, results in embryonic lethality atBE10. (A) Generation of a genetically modified cIap
locus. Exons 2 and 3 of cIap2 were flanked by frt sites and a neomycin phosphotransferase expression cassette and exon 1 of cIap1 was flanked
by loxP sites with an hygromycin cassette. (B) Incidence of genotypes of weaned mice or embryos derived from indicated intercrossed mice;
* represents embryos without heartbeat or reabsorbed and # represents embryos with minimal heart contractile activity. Expected numbers
of each group shown in brackets (based on Mendelian ratios). (C) Detection of cIap1, cIap2 and Xiap expression during development (E10.5) by
in situ hybridization as compared with sense control probe. (D) Expression of IAPs during mouse development detected by western blotting. A
WT E10.5 embryo was lysed in DISC lysis buffer supplemented with protease inhibitors, NEM and Pefabloc. IAPs were trapped using
biotinylated SM and precipitated with streptavidin beads. Lysates (lys), unbound fractions (unb), glycine elutions (ge), and boiled beads (bb)
were separated using SDS/PAGE and blotted with antibodies to cIAP1, cIAP2, and XIAP. 293Tcells transfected with a plasmid encoding mouse
cIAP2DC6 were used as a positive control for detection of cIAP2. See also Supplementary Figure S1. Figure source data can be found in
Supplementary data.
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mice (cIap2FRT/FRTcIap1lox/lox) are viable and fertile and have
a normal phenotype (Supplementary Figure S1A). FlpE
(Rodriguez et al, 2000) and Cre-deleter (Schwenk et al,
1995) mice were used to generate germline deletions of the
cIap1 and cIap2 locus either individually or together, and
some were subsequently crossed with mice bearing Xiap
mutant alleles. Both the cIap2FRT/FRTcIap1/ and cIap2/
cIap1lox/lox single mutant mice were viable and showed no
reproductive or developmental defects (Supplementary
Figure S1A), consistent with previous reports of indepen-
dently generated cIap2 or cIap1-deficient mice (Conze et al,
2005; Conte et al, 2006). Among 4200 progeny of 40 cIap2þ /
cIap1þ / intercrosses, no homozygous cIap2/cIap1/ mice
were found, whereas double heterozygote and wild-type (WT)
genotypes were present in a ratio of 2 to 1 (Figure 1B;
Supplementary Figure S1B). This indicates that the absence of
both cIAP1 and cIAP2 results in lethality at or before birth.
Therefore, at least for development, cIAP1 and cIAP2 are redun-
dant, but presence of at least one allele of either gene is required
and sufficient for viability. Similarly, mice bearing one or two
copies of the gene for cIap1 (i.e., Xiap/cIap1þ / and Xiap/
cIap1þ /þ mice, respectively) were found in a ratio of 2 to 1,
indicating lethality of embryos lacking both cIAP1 and XIAP
(Figure 1B). In contrast, mice that lacked genes for both XIAP
and cIAP2 were viable and fertile without any obvious phenotype
(Figure 8, Supplementary Figure S1A, and data not shown).
Together, these results show that cIAP1 is sufficient for develop-
ment in the absence of cIAP2 and XIAP, but that presence of both
cIAP2 and XIAP are needed if cIAP1 is absent.
All three IAPs are expressed during early mouse
development
To determine the expression and distribution of the three
IAPs during development, we analysed cIAP1, cIAP2, and
XIAP embryonic expression by in situ hybridization using
sections of WT embryos from E9.5 to E15.5. Dark field
photographs are shown in Figure 1C. Ubiquitous expression
of cIAP1, cIAP2, and XIAP was observed at all stages, with
the strongest expression being at E9.5 and E12.5. We also
determined levels of IAP proteins by lysing whole E10.5
embryos, and immunoprecipitating using a biotinylated IAP
antagonist/Smac mimetic (SM) (compound A, TetraLogic
Pharmaceuticals) (Vince et al, 2007). Consistent with the
in situ hybridization data, all three IAPs could be pulled
down with the biotinylated compound at E10.5 (Figure 1D
and data not shown). These results showed that cIAP1,
cIAP2, and XIAP are all expressed during mouse develop-
ment, and of these three proteins, only cIAP1 is sufficient to
act alone to allow normal development.
Cardiovascular defect in cIap2/cIap1/ and Xiap/
cIap1/ DKO embryos
To determine the cause of death of the double IAP-deficient
embryos, we examined them from E9.5 to E14.5. At each
stage, no differences were observed between WT embryos
and double heterozygote cIap2þ /cIap1þ /, Xiap/cIap1þ /
and Xiap/ embryos. At E9.5, all cIap2/cIap1/ and Xiap/
cIap1/ embryos were viable and could not be distinguished by
overall morphology from WT or Xiap/ embryos. However,
between E10.5 and E11.5, we observed that the pericardial
cavities of double homozygous mutant embryos were frequently
swollen and filled with blood (Figure 2A and B). In most cases,
mutant embryos were found with minimal or no contractile
activity of the heart. Placentas appeared normal by gross mor-
phology and histology (data not shown). Transverse serial sec-
tions of the mutant embryos showed that most tissues appeared
normal, except for the heart, which showed sporadic disconti-
nuities, usually in the atrial chamber. These discontinuities were
often in association with pyknotic nuclei, suggestive of apoptosis
(Figure 2C and D). However, elsewhere in the embryos we saw
no major differences in the overall pattern of apoptosis between
WT, Xiap/, cIap2/cIap1/ and Xiap/cIap1/ embryos
(head and eye sections are shown as examples in Figure 2E
and F). We conclude that the lethal phenotype of cIap2/
cIap1/ and Xiap/cIap1/ embryos is not due to generalized
growth retardation or widespread failure to control cell death, but
is due to haemorrhages and cardiovascular failure at BE10.5.
In mouse embryonic fibroblasts, only cIAP1 is necessary
for normal induction of canonical NF-jB by TNF, and it is
the only IAP that allows TNF to activate NF-jB without
other IAPs
Previous studies using cIap/ mouse embryonic fibroblasts
(MEFs) and siRNA have shown that cIAPs are required for
TNF to efficiently activate canonical p65/RelA NF-kB in
cultured cells (Mahoney et al, 2008; Varfolomeev et al,
2008). To further investigate the roles of the IAPs in NF-kB
activation, we generated MEFs from cIap2/cIap1/,
Xiap/cIap1/ and Xiap/cIap2/ DKO embryos and
immortalized them with SV40 large T antigen. We used
western blotting to determine the levels of the three IAPs in
each DKO MEF line. As expected, cIAP1 was absent from the
cIap2/cIap1/ and Xiap/cIap1/ lines, and was pre-
sent at similar levels in WT and Xiap/cIap2/ lines
(Figure 3A). Similarly, XIAP was absent from the Xiap/
cIap1/ and Xiap/cIap2/ lines, and present in the
cIap2/cIap1/ line. In contrast, cIAP2 was not only absent
from cIap2/ lines, but was also not detectable in WT MEFs
or Xiap/cIap1/ MEFs, presumably reflecting either low
levels of transcription in unstimulated MEFs, protein instabil-
ity, or low sensitivity of the antibody. Because the same
antibody readily detected cIAP2 in embryos that was immu-
noprecipitated by a biotinylated SM compound, as well as
overexpressed cIAP2 (Figure 1D), we believe unstimulated
MEFs normally contain very low levels of cIAP2.
Previously, we have found elevated levels of NIK, and
processing of NF-kB2 to p52, in unstimulated cIap1/ and
cIap2/cIap1/ MEFs, suggesting that a normal function of
cIAP1 is to promote degradation of NIK in cells that have not
been treated with cytokine (Vince et al, 2007; Feltham et al,
2010). Consistent with these observations, we found high
levels of NIK and activation of non-canonical NF-kB and
processed p100 NF-kB2 in untreated Xiap/cIap1/ MEFs
(Figure 3A). In contrast, the amount of NIK, p100 and p52 in
Xiap/cIap2/ MEFs were similar to those in WT MEFs.
Therefore, the presence of cIAP1 is both necessary and
sufficient to cause degradation of NIK and prevent sponta-
neous activation of non-canonical NF-kB in untreated cells.
Furthermore, the presence of cIAP1 was also both necessary
and sufficient for TNF to promote phosphorylation of
canonical p65/RelA NF-kB, and trigger degradation of IkBa
(Figure 3B). These results also show that, on its own, XIAP
is not able to activate canonical NF-kB following TNF
stimulation of MEFs, and that cIAP2 is also not able, or is
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not present at high enough levels, to signal activation of
canonical NF-kB, confirming that cIAP1 is the most important
IAP for regulation of canonical and non-canonical NF-kB
both in MEFs and for development.
Lack of cIAP1 sensitizes MEFs to TNF-induced
apoptosis, but loss of both cIAP2 and XIAP does not
Low levels of cIAP1, whether due to gene deletion or treat-
ment with SM, sensitized MEFs to TNF-induced cell death
(Varfolomeev et al, 2007; Vince et al, 2007). Consistent with
this, WT MEFs were not killed by TNF, but the cells died
when TNF was combined with SM (Figure 4A). cIap2/
cIap1/ and Xiap/cIap1/ MEFS were very sensitive to
induction of cell death by TNF alone (Figure 4A). Compared
with WT MEFs, those lacking both cIAP1 and cIAP2, or both
cIAP1 and XIAP, were also much more sensitive to killing by
CD95L (Fas ligand), or the topoisomerase II inhibitor etopo-
side, but not the DNA alkylating agent cisplatin (Figure 4A).
Surprisingly, Xiap/cIap2/ MEFs were similar to WT
MEFs, because they were not killed by TNF alone, but
could be significantly sensitized by addition of SM, which
depletes the cells of cIAP1.
To investigate further the ability of cIAPs to regulate TNF-
induced cell death, we complemented the cIap2/cIap1/
and Xiap/cIap1/ MEFs with WT cIAP1, EGFP-tagged
cIAP1, Flag–cIAP2, or XIAP, expressed from a tamoxifen-
inducible lentiviral vector. EGFP-tagged cIAP1 and XIAP
proteins were functional because they bound TRAF2 and
Smac/DIABLO, respectively (Supplementary Figure S2).
Induction of cIAP1 or Flag–cIAP2 by 4-hydroxy-tamoxifen
(4-HT) in cIap2/cIap1/ MEFs, and induction of EGFP–
cIAP1 in Xiap/cIap1/ MEFs made cells almost as resis-
tant to TNF-induced death as WT MEFs (Figure 4B and D).
Even the low background levels of cIAPs expressed from the
uninduced lentiviral vector (Figure 4C and E) gave partial
protection against TNF killing (Figure 4B and D). Moreover,
reconstitution with cIAP1 or XIAP was able to give partial
protection to Xiap/cIap1/ MEFs against CD95L-induced
cell death, but cIAP1 seemed to be more potent than XIAP
(Figure 4D). Similarly, overexpression of XIAP in cIap2/
cIap1/ MEFs provided no protection, and reconstitution of
XIAP into Xiap/cIap1/ MEFs provided only modest
protection from killing by TNF (Figure 4B and D). These
data demonstrate that unlike cIAP1, XIAP is neither
Figure 2 Embryonic lethality of cIap2/cIap1/ and Xiap/cIap1/ DKO embryos. (A, B) Whole view of E10.5 and E11.5 embryos derived
from intercrosses of cIap2þ /cIap1þ / and Xiap/cIap1þ / mice, respectively. In the DKO embryos, blood has accumulated in the pericardial
cavities, but not in those of WT or Xiap/ littermates. (C, D) Histological analysis of the atria from a WT and cIap2/cIap1/ DKO E10.5
embryo and Xiap/ and Xiap/cIap1/ DKO E11.5 embryos. The arrow shows discontinuity in the wall. (E, F) TUNEL (green) staining
indicating fragmented DNA and nuclear (DAPI, blue) staining of E10.5–E11.5 transverse sections of embryos with genotypes as indicated.
Heads are shown in the top panels and eyes are shown in the bottom panels. No gross differences in patterns of TUNEL-stained cells were
observed.
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necessary nor sufficient to block apoptosis pathways
activated by TNF in MEFs.
Deletion of Tnfr1, but not Tnfr2, allows cIap2/cIap1/
embryos to develop until birth
Previous studies have shown that deletion of genes for Tnfr1
prevents death of p65/RelA NF-kB KO and Traf2 KO mice
during embryonic development, and allows them to survive
until shortly after birth (Nguyen et al, 1999; Rosenfeld et al,
2000). Because MEFs derived from p65/RelA KO and Traf2 KO
mice resemble those derived from cIap1 KO mice, in that they
are all very sensitive to induction of apoptosis by TNF alone,
and all show deficits in activation of canonical (p65/RelA)
NF-kB in response to TNF, we hypothesized that deletion of
Tnfr1 would allow cIap2/cIap1/ embryos to survive until
birth. We therefore generated cIap2/cIap1/Tnfr1/ tri-
ple KO mice. Unlike the cIap2/cIap1/ embryos, most of
the cIap2/cIap1/Tnfr1/ pups were born alive
(Figure 5A and B). Some of them survived until day 2 with
no overt phenotype, but no the cIap2/cIap1/Tnfr1/
mice were found at weaning. In contrast, deletion of TNFR2
was not able to prolong survival of cIap2/cIap1/ em-
bryos (Figure 5A). To further analyse the relative contribu-
tions of the two different TNF receptors in death induced by
TNF, we generated MEFs from cIap2/cIap1/Tnfr1/ and
cIap2/cIap1/Tnfr2/ embryos and immortalized them
with SV40 large T antigen. For comparison, we generated WT,
Tnfr1 KO, and Tnfr2 KO MEFs. As expected, none except
the cIap2/cIap1/ Tnfr2/ MEFs was killed by TNF
alone (Figure 5C). Moreover, all MEF lines lacking Tnfr1
were resistant to TNF even in the presence of SM. These results
demonstrate that death of cIap2/cIap1/ MEFs in response
to TNF, and death at E10.5 of cIap2/cIap1/ embryos, are
both dependent on the presence of TNFR1 but not TNFR2.
TNF can activate both caspase-dependent and caspase-
independent, RIPK1 kinase-dependent cell death
mechanisms
The amount of cell death induced by signalling through
TNFR1 is greatly increased when IAPs are absent, in
cIap2/cIap1/ embryos as well as in MEFs, whether
cIAPs are absent due to gene deletion or treatment with
SM. To determine if TNF causes cell death via a caspase- or
a RIPK1-dependent mechanism, we analysed the effect of
adding a pan-caspase inhibitor, QVD-OPh (QVD) (Caserta
et al, 2003), and a specific RIPK1 kinase inhibitor, necrostatin
(Degterev et al, 2008). In all types of cells tested (WT, Xiap/
cIap2/, cIap2/cIap1/, Xiap/cIap1/), TNF caused
death when cIAP1 was genetically deleted, or was reduced by
treatment with SM (Figure 6A). Moreover, in every case, TNF-
induced cell death could be almost entirely blocked when QVD
and necrostatin were added together (Figure 6A, black col-
umns). When added alone, the degree of protection provided
by necrostatin (Figure 6A, light grey columns) appeared to
correlate with the amount of remaining IAP. In contrast, the
extent of protection by QVD was greater when cIAP1 was
genetically deleted than when it was reduced by SM treatment.
These results suggest a larger role for caspases, but a lesser role
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Figure 3 Defects in NF-kB signalling in the absence of cIAP1. (A) Levels of NIK, and spontaneous processing of p100 is increased in MEFs
lacking cIAP1. SV40 large Tantigen-immortalized MEFs derived from WT, cIap2/cIap1/ DKO, Xiap/cIap2/ DKO, and Xiap/cIap1/
DKO embryos, were lysed then separated using SDS/PAGE and probed with antibodies to cIAP1, cIAP2, XIAP, NIK, p100/p52, and FADD
(* indicates non-specific bands due to the antibody to NIK). Lysate from 293Tcells transfected with a plasmid encoding murine cIAP2 DC6 was
used as a positive control for detection of cIAP2. (B) TNF does not efficiently trigger IkB degradation in cIap1 deleted cells. Cells described in
(A) were incubated with or without 100 ng/ml Fc-TNF for the indicated times. Lysates were separated using SDS/PAGE and probed for
phosphorylated p65, IkBa, RIPK1, and TRAF2 and b-actin. Figure source data can be found in Supplementary data.
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for RIPK1 kinase activity, in TNF-induced death in the absence
of cIAP1. Furthermore, in agreement with previous results
(Haas et al, 2009), ubiquitylation of RIPK1 was reduced in the
absence of both cIAP1 and cIAP2, but the amount of unmodi-
fied RIPK1 bound to the TNFR1 signalling complex was in-
creased (Figure 6B). Findings were similar in Xiap/cIap1/
cells, whereas normal levels of RIPK1 ubiquitylation were
observed when only cIAP1 was present (i.e., in Xiap/
cIap2/ MEFs) (Figure 6B). These experiments indicate that
in MEFs, TNF mainly activates a caspase-dependent death
process, but provide some evidence, suggesting that it can
also activate a caspase-independent, RIPK1 kinase-dependent
death mechanism, which is more apparent when cIAP1 levels
are reduced by SM, than when cIAP1 is eliminated by gene
deletion.
cIap2/cIap1/ E10.5 cardiac defects are absent if
Ripk1 or Ripk3 genes are deleted, and heterozygosity for
Ripk1 allows Xiap/cIap1/ mice to survive
embryogenesis
The ability of necrostatin to increase survival of MEFs
with reduced levels of IAPs when exposed to TNF raised
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Figure 4 Endogenous levels of cIAP1, and ectopic expression of cIAP2, protect MEFs from killing by TNF much more than XIAP. (A)
Sensitivity of gene deleted lines to induction of cell death. Cells described in Figure 3A were incubated for 24 h with 100 ng/ml Fc-TNF or 20 ng
Fc-CD95L, 500 nM SM, 1mM etoposide or 5 mg/ml cisplatin where indicated. Cells were stained with PI and analysed by flow cytometry. The
meanþ s.e.m. of 3–11 independent experiments is shown. (B, C) Ability of ectopically expressed IAPs to protect cIap2/cIap1/ DKO cells.
cIap2/cIap1/ MEFs were complemented with inducible mouse cIAP1, FLAG–cIAP2, or mouse XIAP and induced with 10 nM 4-HT for 24 h,
and then incubated with or without 100 ng/ml Fc-TNF for a further 24 h. Cells were stained with PI and analysed by flow cytometry. The mean
valuesþ s.e.m. of 5–14 independent experiments are shown (* indicates a non-specific band). (D, E) Ability of ectopically expressed IAPs to
protect Xiap/cIap1/ DKO cells. Xiap/cIap1/ MEFs were complemented with inducible mouse cIAP1 or EGFP–XIAP, induced with
10 nM 4-HT for 24 h and then treated with 100 ng/ml Fc-TNF or 20 ng/ml Fc-CD95L and 500 nM SM. The mean valuesþ s.e.m. of three to six
independent experiments are shown. See also Supplementary Figure S2. Figure source data can be found in Supplementary data.
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the possibility that the death of cIap2/cIap1/ and Xiap/
cIap1/ DKO embryos at day E10.5 might also involve RIPK1
or RIPK3. To test this, we generated Xiap/cIap1/Ripk1/,
cIap2/cIap1/Ripk1/, and cIap2/cIap1/Ripk3/
mice. Xiap/cIap1/Ripk1/ embryos were viable to
E14.5, but by E15.5, they had died. Surprisingly, Xiap/
cIap1/Ripk1þ / mice were born alive (Figure 6C). While
most Xiap/cIap1/Ripk1þ / mice died within the first 10
days of birth, two runted males even survived for 6 weeks
(Figure 6C; Supplementary Figure S3B and C). Unlike the
cIap2/cIap1/ embryos that never survive past E10.5,
cIap2/cIap1/Ripk1/ and cIap2/cIap1/Ripk3þ /
embryos survived to E12.5, and cIap2/cIap1/Ripk1þ /
and cIap2/cIap1/Ripk3/ embryos survived to E15.5
(Figure 7A and C). Six out of seven cIap2/cIap1/
Ripk1þ / embryos were viable at E12.5 and three embryos
were found dead at E15.5 (Figure 7B and D). Four cIap2/
cIap1/Ripk3/ embryos were viable at E13.5 and three
embryos were found dead around E15.5 (Figure 7C). These
results show that the absence of RIPK3 or loss of only one
allele of Ripk1 can overcome the mid-embryonic lethality in
cIap2/cIap1/ or Xiap/cIap1/ mutant mice, respec-
tively. Moreover, the presence of cIap2 allowed the further
development of Xiap/cIap1/Ripk1þ / to birth, but Xiap
was not sufficient for cIap2/cIap1/Ripk1þ / embryos to
survive beyond E15.5. Together with the data presented
above, these results indicate that of the IAPs, only cIAP1 is
sufficient on its own to prevent RIP kinases from acting in the
TNF receptor signalling pathway to cause mid-embryonic
lethality.
Discussion
Consistent with earlier reports, we found that mice lacking a
single IAP, either cIap1, cIap2, or Xiap, are viable and fertile
and exhibit relatively subtle phenotypes (Harlin et al, 2001;
Conze et al, 2005; Conte et al, 2006). To study the functional
redundancy of the IAPs, we examined compound IAP mutant
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Figure 5 Deletion of Tnfr1, but not Tnfr2 allows cIap2/cIap1/ embryos to develop until birth. (A) Incidence of genotypes of weaned mice
or embryos derived from intercrosses of genotypes as indicated; * represents embryos without heartbeat or reabsorbed. Expected numbers of
each group are shown in brackets. (B) Representative photographs of three 1-day-old pups from a litter from a cIap2þ /cIap1þ /Tnfr1/
intercross. (C) Sensitivity to TNF is conferred by TNFR1 not TNFR2. SV40 large T antigen transformed MEFs derived from WT embryos or
mutant embryos as indicated were incubated for 24 h in the presence or absence of 100 ng/ml Fc-TNF and 500 nM SM. Cells were stained with
PI and analysed by flow cytometry. The mean valuesþ s.e.m. of three to seven independent experiments are shown.
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mice. While those lacking both cIAP2 and XIAP were viable
and fertile, without any obvious developmental phenotype, in
marked contrast, cIap2/cIap1/ and Xiap/cIap1/
DKO mice died in utero after 10 days of development.
The phenotype of the compound mutants implied that all
three IAPs are expressed during early embryogenesis.
However, Shafey et al (2006), who used cIap2 null, lacZ
reporter mice, concluded that cIAP2 was not expressed before
E11.5. To resolve this, we performed immunoprecipitations
using biotinylated SM, and analysed them by western blot.
Using this technique, we were able to detect cIAP2 from
E10.5, which suggests that at this stage of embryogenesis all
three IAPs are expressed, but cIAP2 protein is present at
comparatively low levels. These low levels of cIAP2 protein,
together with the easily detectable mRNA revealed by in situ
hybridization, are consistent with cIAP2 having a shorter
half-life than cIAP1, which might be due to an increased
propensity for cIAP2 than cIAP1 to spontaneously dimerize,
autoubiquitylate, and be degraded (Feltham et al, 2011).
The double IAPs-deficient embryos and placentas
appeared normal with the exception of the heart. The
appearance of these embryos bore similarities to zebrafish
mutant for their single cIAP gene (Santoro et al, 2007).
These embryos exhibit the tomato phenotype, characterized
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Figure 6 In the absence of IAPs, both TNF-induced death of MEFs, and embryonic death during development, involves RIPK1. (A) Together,
the RIPK1 kinase inhibitor necrostatin and the caspase inhibitor QVD protect IAP gene deleted MEFs from killing by TNF. MEFs derived from
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by severe haemorrhage and vascular regression during devel-
opment. A similar phenotype is also seen in mouse embryos
lacking other genes in the, death receptor signalling pathway
(Figure 8A), such as Fadd, Casp8, and Flip mutants
(Varfolomeev et al, 1998; Yeh et al, 1998, 2000). This raised
the possibility that there might be common mechanisms for
the developmental deaths of the embryos, even though some
of the proteins (e.g., FADD and caspase 8) are generally
thought to be pro-apoptotic, whereas others (e.g., FLIP and
IAPs) are generally thought to promote survival or inhibit
apoptosis. Interestingly, apoptosis (as revealed by TUNEL
(terminal deoxynucleotidyltransferase-mediated dUTP-biotin
nick end labelling) staining) was unremarkable in the cIap2/
cIap1/ embryos, just as it was in the Fadd/, Casp8/,
and Flip/ mutants, raising the possibility that some other
cell death process, such as necroptosis (Hitomi et al, 2008)
might be involved.
Depending on the cell type and environment, TNFR1
signalling can result in a variety of responses in living cells,
or death of cells by apoptosis or necroptosis. We found that in
untreated cells, cIAP1 played a much more important role
than cIAP2 and XIAP in limiting levels of NIK, and cIAP1 was
the most critical IAP for activating canonical p65/RelA NF-kB
to prevent TNF-induced cell death. In MEFs, only cIAP1 was
necessary and sufficient to stop cells dying when they were
exposed to TNF, or to allow TNF to rapidly activate p65/RelA
NF-kB. cIAP1 was necessary and sufficient to cause degrada-
tion of NIK, and prevent the spontaneous activation of the
non-canonical p100/p52 NF-kB2 pathway. In contrast, in the
absence of cIAP1, neither cIAP2 nor XIAP allowed TNF to
activate NF-kB. Our results confirm that cIAP1 is a crucial
regulator of both canonical and non-canonical NF-kB, in both
resting and TNF-stimulated cells.
In MEFs, TNF mainly activated a caspase-dependent death
process, but it could also activate a caspase-independent,
RIPK1 kinase-dependent death mechanism. The differences
in the ability of QVD and necrostatin to block TNF-induced
cell death in cIAP1 gene deleted MEFs compared with MEFs
depleted of cIAP1 by SM suggest a complex interaction
between cIAP1 and RIPK1. One possibility is that the amount
of ubiquitylation of RIPK1 by cIAP1 determines the outcome
following TNF treatment. In normal cells, TNF triggers cIAP1
to poly-ubiquitylate RIPK1, which efficiently activates p65/
RelA NF-kB, but RIPK1 is then degraded and no cell death
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Figure 7 Prevention E10.5 lethality of cIap2/cIap1/ embryos by deletion of Ripk1 or Ripk3 genes. (A) Incidence of genotypes of born pups
or embryos derived from intercrosses of cIap2/cIap1þ /Ripk1þ / mice. (B) Representative photographs of E12.5 embryos from a cIap2þ /
cIap1þ /Ripk1þ / intercross. (C) Incidence of genotypes of embryos derived from crosses of cIap2þ /cIap1þ /Ripk3þ /þ orþ /or/ females
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occurs; if cIAP1 levels are reduced by SM, RIPK1 is ubiqui-
tylated to a small extent, which increases its ability to cause
cell death by a necrostatin blockable, caspase-independent
mechanism; and if no cIAP1 is present, there is no RIPK1
ubiquitylation, and most of RIPK1 remains within the TNFR1
signalling complex to help recruit and activate caspase 8.
Recently, deletion of RIPK1 was shown to rescue the
embryonic lethality of Fadd null embryos to birth (Zhang
et al, 2011), and deletion of RIPK3, which is thought to act
downstream of RIPK1 in the necroptotic pathway, was shown
to allow Casp8 KO mice to develop into normal, fertile adults
(Ch’en et al, 2011; Kaiser et al, 2011; Oberst et al, 2011)
(Figure 8A). However, later in life, mice lacking both RIPK3
and caspase 8 develop a progressive lymphoaccumulative
disease, a phenotype similar to Fas deficiency (Kaiser et al,
2011; Oberst et al, 2011). These experiments imply that FADD
and caspase 8 are required to inhibit RIPK1 and/or RIPK3,
which, when left uncontrolled, cause lethal developmental
defects at E10.5. Our observations of the cIap2/cIap1/
Ripk1þ / and cIap2/cIap1/Ripk3/ mice suggest that
cIAPs inhibit RIPK activity during development, presumably
through ubiquitylation (Bertrand et al, 2008), whereas FADD
and caspase 8 limit RIPKs by proteolysis (Pastorino et al,
1999; Feng et al, 2007). Furthermore, inhibition of RIPKs by
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Casp8 –/–
Fadd –/–
Xiap is not enough 
~ E12.5 
B
A
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Ripk1 –/–
+ Ripk3 –/–
+ Ripk1 –/–
+ Ripk1 –/–
+ Ripk3 –/–
+ Ripk3 +/–
+ Ripk1 +/–
+ Ripk1 +/–
Ripk3 –/–
Xiap –/– cIap2 –/–
Xiap –/– cIap1 –/–
cIap2 –/– cIap1 –/–
cIAP1 is enough cIAP1 is enough 
ApoptosisNecrosis
TNFR1
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RIPK3
FADD 
RIPK1
Casp8
IAPs
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p100–p52 NF-κB2NIK
Secreted TNF 
p65/RelA
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Figure 8 Roles of cIAPs in signalling and cell death during development. (A) Diagram of extent of viability of single, double, and triple gene
deleted mice. (B) Speculative model to account for the phenotypes of gene deleted mice. Binding of TNF to TNFR1 triggers (large blue arrow)
formation of complexes that can culminate in cell death by apoptosis or necroptosis, or lead to cell survival. Activating interactions are
indicated with blue arrows; inhibitory interactions are indicated with orange lines; transcriptional induction is indicated with grey arrows.
Merging of lines (such as those from Casp8 and FLIP to RIPK1, or IAPs and RIPK1 to p65/RelA) indicate proteins that can act together. cIAPs
limit levels of NIK, and inhibit cell death mediated by RIPK1 and RIPK3, but cooperate with RIPK1 to activate p65/RelA. RIPK1 has both
pro-death and pro-survival functions, by promoting necroptosis via RIPK3, apoptosis via FADD and Casp8, and cell survival via p65/RelA.
Casp8 inhibits cell death by necrosis, but promotes cell death by apoptosis. FLIP inhibits cell death by both pathways. This model is not
complete, and does not include other important proteins, such as TRADD, TRAF2, CYLD, A20, TAK1, HOL, HOIP, or Sharpin, just to name a
few. For further details, see Discussion.
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FADD/caspase 8 or cIAP1/2 alone is not sufficient to prevent
RIPK-dependent embryonic lethality, rather, both FADD/cas-
pase 8 and cIAP1/2 are required to control RIP kinases.
Together, these results show that mouse development is
relatively normal in the absence of cIap1 alone, or the
absence of both cIap2 and Xiap. Therefore, the critical IAP
functions can be fulfilled by just cIAP1, or by XIAP and cIAP2
acting together. Perhaps, cIAP2 on its own might not be
present at high enough levels for normal development to
proceed, but when XIAP is also present, it supports cIAP2’s
function, either by inhibiting caspases, by binding to TAB1,
or by sequestering BIR-binding proteins (such as Smac/
DIABLO).
Remarkably, because deletion of Tnfr1 rescued develop-
ment of cIap2/cIap1/ embryos to birth, either TNF
signalling occurs as early as E10.5, and this will lead to
embryonic lethality unless it is controlled by IAPs, or, IAPs
are needed to prevent aberrant production of TNF, just as
depletion of IAPs by SM provokes autocrine production of
TNF by some tumour cell lines (Vince et al, 2007).
Regardless, the pathway activated by TNF during develop-
ment of cIap2/cIap1/ embryos must involve RIPK1 and
RIPK3, because rather than dying at E10.5, cIap2/cIap1/
embryos that lacked both copies of Ripk3, or Xiap/
cIap1/ and cIap2/cIap1/ embryos hemizygous for
Ripk1, were able to survive to E15.5 or longer, sometimes
surviving beyond birth.
A possible model to account for these observations is
shown in Figure 8B. According to this model, ligation of
TNFR1 can trigger formation of a complex (sometimes
termed the ‘ripoptosome’) in which RIPK1, RIPK3, and
FADD interact in complex ways. When activated, RIPK1
does three things: it can activate RIPK3 (which can lead to
necroptosis); together with FADD, it can activate caspase 8
(which can lead to apoptosis); and together with cIAPs, it can
promote activation of canonical (p65/RelA) NF-kB. However,
RIPK1 and RIPK3 are both subject to negative regulation,
both by cIAP-dependent ubiquitylation, and by FADD/FLIP/
caspase 8-mediated cleavage. cIAPs inhibit cell death by
ubiquitylating RIPK1 and RIPK3, by promoting activation of
canonical NF-kB, and by reducing activation of non-canoni-
cal (NIK-dependent) NF-kB. When genes for either FADD,
FLIP, caspase 8, or cIAPs are deleted, RIPK1 and RIPK3 are no
longer restrained, and cause death of cells in the developing
heart at E10. This phenotype can be suppressed by also
deleting genes for RIPK1 or RIPK3. Early activation of
RIPK1 and RIPK3 in the cIap DKOs might be in response to
normal production of TNF, or aberrant production of TNF due
to elevated levels of NIK and p100/p52 NF-kB. According to
this model, deletion of one or both copies of Ripk1 in cIap
DKO mice is able to reduce RIPK1 levels enough to allow
development past E10, but RIPK1 heterozygous mice might
survive better than RIPK1 null mice after birth because in the
absence of cIAPs, RIPK1 heterozygotes probably retain some
ability to activate canonical p65/RelA NF-kB.
Materials and methods
Generation of cIap2FRT/FRT and cIap1lox/lox mice by gene
targeting and timed mating
Animal experimental procedures were approved by the Animal
Ethics Committee of La Trobe University. cIap1lox/lox and
cIap2FRT/FRT constructs are described in Gardam et al (2011). In
order to generate the cIap2FRT/FRTcIap1lox/lox mice, both constructs
were inserted into BRUCE embryonic stem cells, which were
derived from C57BL6 mice (Kontgen et al, 1993; Hughes et al,
2007). The cIap2FRT/FRTcIap1lox/lox mice were crossed to transgenic
mice expressing FLPe recombinase to generate the cIap2/
cIap1lox/lox line, and to mice expressing Cre recombinase to generate
the cIap2FRT/FRTcIap1/ line. The cIap2FRT/FRTcIap1/ mice were
subsequently crossed to FLPe mice to generate the cIap2þ /
cIap1þ / mice then used for timed matings. For all timed matings,
a single male was housed with 2–5 females. The females were
checked each morning for vaginal plugs. When a vaginal plug was
detected, the female was separated from the male. The embryonic
days were counted starting at E0.5 on the day the plug was detected.
The embryos were taken on the embryonic days described
throughout. All animal experiments were in accordance with La
Trobe University Animal Ethics Committee guidelines.
In situ hybridization
In situ hybridization was performed as described previously
(Thomas et al, 2000). Briefly, sections were dewaxed, rehydrated
through graded concentrations of alcohol, incubated for 10 min at
room temperature in 10 mg/ml proteinase K, fixed in 4%
paraformaldehyde 10 min, then dehydrated through graded con-
centrations of alcohol. Sections were air dried, and hybridization
solution containing 5105 counts/min/ml of in vitro transcribed
cRNA probe was placed over the section. Slides were incubated
overnight at 561C and then washed as described (Hogan et al,
1986).
Histological analysis
Embryos were dissected between E10.5 and E11.5, fixed in 4%
paraformaldehyde, paraffin embedded and the serially sectioned
(7 mm). Sections were stained with haematoxylin and eosin or used
unstained for TUNEL and immunofluorescence, which were
conducted as described previously (Thomas et al, 2000).
Generation of MEFs and lentiviral particles
Generation of MEFs has been previously described in detail (Vince
et al, 2007). Briefly, primary MEFs were generated from E9.5/E10.5
(cIap2/cIap1/), E10.5/E11.5 (Xiap/cIap1/), E10.5/E12.5
(cIap2/cIap1/Tnfr2/), E14.5 (cIap2/cIap1/Tnfr1/),
E15.5 (WT, cIap2/cIap1/Tnfr1/, Tnfr2/ and Xiap/
cIap2/) embryos, using standard protocols, and then infected
with SV40 large T antigen expressing lentivirus to generate
immortal cell lines.
Generation of lentiviral particles has recently been described
(Vince et al, 2007; Geserick et al, 2009). Briefly, to generate cIap2/
cIap1/ or Xiap/cIap1/ MEFs expressing inducible mouse
cIAP1, EGFP–cIAP1, Flag–cIAP2, mouse XIAP, or EGFP–XIAP, 293T
cells were transfected with packaging constructs pCMV jR8.2, VSVg
and the relevant lentiviral plasmid. DKO MEFs were infected with
packaged lentivirus and polyclonal MEFs were obtained after
puromycin (2–5 mg/ml: pF 5xUAS selection) and hygromycin
selection (100–500 mg/ml: GEV16 selection). Cells were subse-
quently tested for expression of the respective proteins after 24 h of
induction with 10 or 100 nM 4-HT.
Death assay
Cells were seeded on 12-well tissue culture plates at B40%
confluency and were allowed to adhere for 24 h. Cells were
incubated in the presence or absence of 10 nM 4-OH-tamoxifen
(4-HT) for 24 h, then 100 ng/ml Fc-TNF or 20 ng/ml Fc-CD95L
(Bossen et al, 2006) plus or minus 500 nM SM (compound A), and/
or 10mM QVD were added to cells for 24 h and cell viability
measured by propidium iodide (PI) exclusion using flow cytometry.
In each sample, 10 000 events were measured and the percentages
of PI-negative (viable) cells are shown.
Western blotting
Samples were lysed in DISC lysis buffer containing 1% Triton X-100
supplemented with protease inhibitor cocktail (Roche), N-EthylMa-
leimide (NEM) and pefabloc on ice for 30 min and clarified by
centrifugation. Samples were separated on precast 4–12% poly-
acrylamide gels (Invitrogen) and transferred to nitrocellulose
membranes for antibody detection. The blots were stained with
Ponceau S to confirm the uniformity of protein loading in each lane.
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All membrane blocking steps and antibody dilutions were
performed with 5% skim milk in PBS containing 0.1% Tween 20
(PBS-T). Antibodies were used as follows: monoclonal anti-b-actin
(Sigma), polyclonal mouse anti-TRAF2 1:1000 (Santa Cruz),
monoclonal anti-cIAP1 1:500 (Alexis), monoclonal anti-cIAP2
1:300 (in house), monoclonal anti-XIAP 1:1000 (MBL), anti-
polyclonal RIPK1 1:1000 (BD Biosciences), monoclonal anti-Flag
1:2000 (Sigma), polyclonal anti-phospho p65 1:000 (Cell Signaling),
polyclonal anti-p100–p52 1:1000 (Cell Signaling), polyclonal anti-
IkBa 1:1000 (Cell Signaling), polyclonal anti-NIK 1:1000 (Cell
Signaling). Washing steps were performed with PBS-T. After
incubating with HRP-coupled secondary antibodies, western
blots were visualized by ECL (GE Healthcare, Rydalmere, NSW,
Australia).
Immunoprecipitation of EGFP–cIAP1 and EGFP–XIAP
Xiap/cIap1/ MEFs reconstituted with inducible EGFP–cIAP1 or
EGFP–XIAP were seeded on 10 cm tissue culture plate and induced
for 24 h with 10 nM 4-HT. Cells were lysed in DISC lysis buffer and
GFP fusion proteins were precipitated using GFP–Trap-A beads for
1 h (Chromotek). The beads were washed four times. Samples then
were separated on 4–12% polyacrylamide gels and transferred to
Hybond C nitrocellulose membrane as described in western blotting
section (see above).
TNFR1 signalling complex precipitation
Cells were seeded on 15 cm tissue culture plates and treated for the
indicated time with 1 mg/ml of Fc-TNF. Cells were lysed in DISC
lysis buffer at 41C for 30 min. The lysates were centrifuged for
30 min and the TNF-RSC was precipitated using protein A beads
overnight. The beads were washed four times. Samples then were
separated on 4–12% polyacrylamide gels and transferred to Hybond
C nitrocellulose membrane as described in western blotting section
(see above).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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